Received Feb 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | — |
She is still exhausted until now; inflammation response; severe pain flare-up/developed a tremendous pain; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID:. A 72-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), on 07Jan2025 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "Pain" (unspecified if ongoing), notes: pain management patient. Concomitant medication(s) included: NOVOCAIN. The following information was reported: PAIN (medically significant) with onset 08Jan2025, outcome "recovering", described as "severe pain flare-up/developed a tremendous pain"; FATIGUE (non-serious), outcome "not recovered", described as "She is still exhausted until now"; INFLAMMATION (non-serious), outcome "unknown", described as "inflammation response". The event "severe pain flare-up/developed a tremendous pain" required physician office visit. Therapeutic measures were taken as a result of pain. Clinical course: On 29Jan2025, it was reported that the patient received the Prevnar 20 vaccine. The patient is a pain management patient and get biweekly trigger point injections to manage her pain. The day after the vaccine, she started to have a severe pain flare up that even additional trigger point injections didn't help. Her doctor said that she was having an inflammation response. The patient was still in pain and it's three weeks later. On 30Jan2025, additional context was reported: She is on pain management, and she has been getting biweekly trigger point injections to manage her pain which she was getting these trigger point injections prior to the administration of Prevnar 20. She mentioned that the trigger point injections include Novocain. Three days after receiving the Prevnar 20 vaccine, she developed a tremendous pain. She is still exhausted until now, and the pain is starting to decline in the past three days. The pain she experienced is enough to seek medical attention and agent stated she did seek medical attention. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Pain (pain management patient)
NOVOCAIN